Equity Research, Broker Reports, and media content on Advanced Oncotherapy

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Advanced Oncotherapy
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Advanced Oncotherapy. We currently have 82 research reports from 5 professional analysts.

Open
45.0p
Range Today
43.0/47.0p
52 Week
33.0/60.0p
Daily Volume
67.4k
# Shares
194.6m
Daily Liquidity
(0.03%)
Pension Liability
£0m
Enterprise Value
£87.0m
Market Cap
£87.6m
Latest PE (hist)
Div Yield
Date Source Announcement
16Apr19 10:26 EQS Hardman & Co Research: Advanced Oncotherapy (AVO): Preparing for commercialisation
16Apr19 09:12 EQS Advanced Oncotherapy (AVO-GB): Key talent acquisition reaffirms the promise of LIGHT
16Apr19 07:00 RNS Senior Management Appointment
07Mar19 09:00 RNS Price Monitoring Extension
22Feb19 07:00 RNS Grant of options
01Feb19 07:00 RNS Appointment of Nominated Adviser and Joint Broker
30Jan19 11:45 RNS Schedule 2(g) Disclosure
  • Frequency of research reports

     

  • Research reports on

    Advanced Oncotherapy

  • Providers covering

    Advanced Oncotherapy